←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Combination Therapy
Pasi Janne
MD, PhD
🏢Dana-Farber Cancer Institute🌐USA
Director, Lowe Center for Thoracic Oncology
130
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Pasi Janne is a pioneer in targeted therapy for lung cancer and has contributed to KRAS G12C inhibitor development and combination studies. His work informs sequencing and rational combinations for KRAS mutant non small cell lung cancer. He leads multiple global trials of KRAS targeted combinations.
Share:
🧪Research Fields 研究领域
lung cancer
KRAS G12C
EGFR
targeted therapy
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Pasi Janne 的研究动态
Follow Pasi Janne's research updates
留下邮箱，当我们发布与 Pasi Janne（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment